Eagle Pharmaceuticals, Inc. (19) | Uncategorized (6)
Recent Contracts
-
Announcement, dated March 28, 2022
(Filed With SEC on March 28, 2022)
-
Form of Director Undertaking
(Filed With SEC on March 28, 2022)
-
Lock-up Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Cosmo Pharmaceuticals N.V
(Filed With SEC on March 28, 2022)
-
Co-Promotion Agreement, dated January 7, 2020, between the Registrant and Tyme Technologies Inc
(Filed With SEC on May 11, 2020)
-
Description of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 2, 2020)
-
Co-Promotion Agreement with Tyme Technologies, Inc., dated January 7, 2020
(Filed With SEC on March 2, 2020)